Your session is about to expire
← Back to Search
Intensive Tobacco Treatment for Smoking Cessation in Cancer Patients
N/A
Recruiting
Led By Joseph D Phillips, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will look at how successful an intensive tobacco treatment program is in helping cancer patients quit smoking, checking in at 30 days, 3 months, and 6 months.
Who is the study for?
This trial is for adults aged 18 or older who are actively smoking at the time of their initial cancer consultation, which means they've smoked within the last two weeks. It's not open to those unable to consent or prisoners.Check my eligibility
What is being tested?
The CORE study is testing how well an intensive tobacco treatment program helps cancer patients quit smoking. Success rates will be checked after 30 days, and then again at 3 and 6 months into the treatment.See study design
What are the potential side effects?
Since this trial focuses on a tobacco cessation program rather than a drug, it doesn't have typical medication side effects. However, participants may experience withdrawal symptoms from quitting smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change is smoking status
Secondary outcome measures
Engagement Level with Tobacco Treatment via Telehealth
Motivational Impact of real-time carbon monoxide monitoring
Other outcome measures
Engagement Level With Tobacco Treatment for Low Resource Patients outh!
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive Tobacco TreatmentExperimental Treatment1 Intervention
Patients who consent to study participation will meet with a tobacco treatment specialist in-person initially, then biweekly via telephone or telehealth or face-to-face (or more frequently as needed). They will receive tobacco treatment counseling and support from certified tobacco treatment specialist, which may include pharmacotherapy as indicated. At enrollment, participants will undergo carbon monoxide testing using a carbon monoxide monitor. At baseline, participants will complete the Fagerström Test for Nicotine Dependence, and the Cancer Patient Tobacco Use Questionnaire (C-TUQ).
These tobacco related survey measures will be completed at 3 additional time points: 30 days, 3 months and 6 months.
Group II: Usual Tobacco TreatmentActive Control1 Intervention
All individuals who are identified as tobacco users are offered tobacco treatment which includes proactive, as needed, contacts via in person, telehealth or telephone visits. for tobacco treatment, pharmacotherapy as indicated, and Quitline and SmokefreeTXT referrals
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,543,239 Total Patients Enrolled
Joseph D Phillips, MDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been smoking within the past two weeks before your consultation for cancer.I am 18 years old or older.I am unable to give consent for medical procedures.
Research Study Groups:
This trial has the following groups:- Group 1: Intensive Tobacco Treatment
- Group 2: Usual Tobacco Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are currently involved in this experiment?
"Indeed, clinicaltrials.gov showcases that this medical study is actively seeking patients as of right now. The trial was first advertised on January 19th 2021 and the post has been updated most recently on February 14th 2022. A total of 100 individuals need to be recruited from a single site."
Answered by AI
Is this trial currently seeking participants?
"Affirmative. Clinicaltrials.gov data indicates that this research study, which was first posted on January 19th 2021, is currently recruiting participants. Approximately 100 individuals need to be enrolled from 1 distinct medical facility."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger